Steven R. Bauer, Ph.D., is the Chief of the Cellular and Tissue Therapy Branch (CTTB), in FDA’s Center for Biologics Evaluation and Research, where he supervises scientific staff engaged in review of cell-based biological therapies, policy development in emerging areas of cellular therapies, and research relevant to their use in clinical trials.  Dr. Bauer’s current research focuses on multipotent stromal cell biology and stromal cell-hematopoietic cell interactions that influence development of lymphocytes.  Dr. Bauer earned his Ph.D. in Biochemistry from the University of Maryland in 1986.  From 1986 through 1991, Dr. Bauer was a scientific member of the Basel Institute for Immunology in Basel, Switzerland.  In 1991, Dr. Bauer joined FDA’s Center for Biologics Evaluation and Research in its  Division of Cellular and Gene Therapies.